Drug Name |
Nilutamide
|
||
Synonyms |
Anandron; Nilandron; Nilandrone; Nilutamida; Nilutamidum; Aventis Behring Brand of Nilutamide; Aventis Brand of Nilutamide; Hoechst Brand of Nilutamide; Nilutamida [Spanish]; Nilutamidum [Latin]; N 8534; RU 23908; Anandron (TN); RU 23908-10; RU-23908; Nilutamide (USAN/INN); Nilutamide [USAN:BAN:INN]; Nilutamide [USAN:INN:BAN]; 1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione; 5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)-2,4-imidazolidinedione; 5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin; 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione; 5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)-2,4-imidazolidinedione; 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione
|
||
Drug Type |
Small molecular drug
|
||
Indications |
Prostate cancer [ICD-11: 2C82.0]
|
Approved
|
|
Company |
Aventis Pharmaceuticals Inc.
|
||
Summary |
Nilutamide is an antineoplastic hormone used to treat prostate cancer.
|
||
Target |
Androgen receptor (AR)
Mechanism of Action: Antagonist
|
T11211 |
![]() |
Formula |
C12H10F3N3O4
|
Canonical SMILES |
CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C
|
|
InChI |
1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20)
|
|
InChIKey |
XWXYUMMDTVBTOU-UHFFFAOYSA-N
|
|
CAS Number | CAS 63612-50-0 | |
TTD ID | D0SN9T | |
DrugBank ID | DB00665 | |
PubChem Compound ID | 4493 | |
PubChem Substance ID |
10364
,
5851647
,
7404097
,
7848028
,
7978498
,
8152766
,
11111555
,
11111556
,
11114201
,
11342173
,
11362356
,
11364519
,
11367081
,
11369643
,
11372644
,
11374239
,
11377805
,
11466956
,
11468076
,
11485861
,
11486751
,
11487758
,
11489789
,
11491448
,
11492415
,
11495439
,
12013485
,
14850346
,
17405438
,
24278596
,
26612639
,
26680190
,
26747174
,
26747175
,
26752242
,
29223587
,
46505381
,
47365306
,
47365307
,
47959867
,
48110544
,
48259346
,
48259347
,
48334600
,
49698835
,
49980214
,
50104947
,
50104948
,
50104949
,
50104950
|
|
ChEBI ID | CHEBI:7573 | |
ADReCS Drug ID | BADD_D01568 |
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |